logo-loader
viewTissue Regenix Group PLC

Tissue Regenix hit by cybersecurity breach

The incident is not believed to have impacted its UK operations or financial systems.

Tissue Regenix Group PLC -
Tissue specialises in skin, bone and organ grafts

AIM-listed regenerative medtech Tissue Regenix Group PLC (LON:TRX) has temporarily closed its manufacturing plant in Texas after a cybersecurity breach.

The incident involved unauthorised access to its computer systems and those of its third-party IT service provider in the United States. 

Investigations are underway using forensic cybersecurity experts with the company also working to quantify the potential financial impact and what is covered by its business disruption insurance.

The incident is not believed to have impacted its UK operations or financial systems.

Quick facts: Tissue Regenix Group PLC

Price: 0.47 GBX

AIM:TRX
Market: AIM
Market Cap: £5.51 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tissue Regenix Group PLC named herein, including the promotion by the Company of Tissue Regenix Group PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Tissue Regenix increasing throughput in its facility to meet 'exceptional...

Tissue Regenix PLC's (LON:TRX) Gareth Jones caught up with Proactive's Andrew Scott to update on developments in the regenerative medical devices maker's second half. ''The focus is really on increasing throughput in our San Antonia facility in the United States to allow us to meet the demand...

on 19/12/19

2 min read